A0652 CORE-008 Cohort B: Evaluating intravesical cretostimogene grenadenorepvec in patients with high-risk, BCG-exposed non-muscle invasive bladder cancer

European Urology 2026

View at publisher

Authors: T.J. Bivalacqua, S. Daneshmand, E. Cone, C. Pieczonka, Laurence H Belkoff, Matthew Mossanen, V. Narayan, G. Steinberg

DOI: 10.1016/s0302-2838(26)00703-7

Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Urinary Bladder and Prostate Research